Tonix Pharmaceuticals Holding is a development-stage specialty pharmaceutical company focused on the development of pharmaceutical products for central nervous system conditions. The company’s lead product candidates include TNX-102, for the management of fibromyalgia syndrome; and TNX-105, for the treatment of post-traumatic stress disorder. TNXP’s pipeline includes various other product candidates that are under evaluation, such as TNX-201, which is a treatment for certain types of headaches; and TNX-301, a potential treatment for alcohol dependence and addiction. For more information visit the company’s Web site at: www.tonixpharma.com
Aegis Capital Corp. is a full service retail and institutional broker-dealer located in New York City. Aegis Capital’s management is committed to providing the highest level of service to its clients. The firm realizes this goal by running an independent, conflict-free platform that is focused on enhancing the goals of clients by bringing unencumbered advice, which enables them to freely create a plan centered on each client. For more information on Aegis Capital, visit www.aegiscapcorp.com.
Let us hear your thoughts below: